Bloomberg Business

PepsiCo Boosts Forecast as Sales Withstand Ozempic Threat

PepsiCo Inc. says appetite-suppressing drugs haven’t affected sales of its snacks and sodas so far, though the company is focused on package size and consumers’ portion-control concerns as it aims to reach its raised annual forecast.

Close Bitnami banner
Bitnami